These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16375164)

  • 1. Health for life. Addiction: how to break the chain.
    Miller MC
    Newsweek; 2005 Dec; 146(24):58. PubMed ID: 16375164
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathological gambling: focusing on the addiction, not the activity.
    Tamminga CA; Nestler EJ
    Am J Psychiatry; 2006 Feb; 163(2):180-1. PubMed ID: 16449466
    [No Abstract]   [Full Text] [Related]  

  • 3. Contingency management: utility in the treatment of drug abuse disorders.
    Stitzer ML; Vandrey R
    Clin Pharmacol Ther; 2008 Apr; 83(4):644-7. PubMed ID: 18305456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone as negative reinforcement comments on "A behavioral analysis of coerced treatment for addicted offenders".
    Farabee D
    J Subst Abuse Treat; 2006 Sep; 31(2):141-2. PubMed ID: 16919740
    [No Abstract]   [Full Text] [Related]  

  • 5. Internet sex addiction treated with naltrexone.
    Bostwick JM; Bucci JA
    Mayo Clin Proc; 2008 Feb; 83(2):226-30. PubMed ID: 18241634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical uses of naltrexone: a review of the evidence.
    Modesto-Lowe V; Van Kirk J
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
    Colker AC
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-6. PubMed ID: 12875273
    [No Abstract]   [Full Text] [Related]  

  • 8. Epigenetic pharmacotherapy for substance use disorder.
    Sartor GC
    Biochem Pharmacol; 2019 Oct; 168():269-274. PubMed ID: 31306644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of addictions.
    Kreek MJ; LaForge KS; Butelman E
    Nat Rev Drug Discov; 2002 Sep; 1(9):710-26. PubMed ID: 12209151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The social implications of neurobiological explanations of resistible compulsions.
    Carter A; Hall W
    Am J Bioeth; 2007 Jan; 7(1):15-7. PubMed ID: 17366154
    [No Abstract]   [Full Text] [Related]  

  • 11. Addiction: the dark side of learning.
    Balland B; Lüscher C
    Pediatr Res; 2008 Jan; 63(1):1. PubMed ID: 18097302
    [No Abstract]   [Full Text] [Related]  

  • 12. A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry.
    Gold MS; Badgaiyan RD; Blum K
    Psychiatr Clin North Am; 2015 Sep; 38(3):419-62. PubMed ID: 26300032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence.
    Brabant C; Alleva L; Quertemont E; Tirelli E
    Prog Neurobiol; 2010 Nov; 92(3):421-41. PubMed ID: 20638439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone: A Pan-Addiction Treatment?
    Aboujaoude E; Salame WO
    CNS Drugs; 2016 Aug; 30(8):719-33. PubMed ID: 27401883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The μ-opioid receptor and treatment response to naltrexone.
    Thorsell A
    Alcohol Alcohol; 2013; 48(4):402-8. PubMed ID: 23543091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A range of research-based pharmacotherapies for addiction.
    O'Brien CP
    Science; 1997 Oct; 278(5335):66-70. PubMed ID: 9311929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narcotic antagonists: naltrexone progress report: foreword.
    Jaffe J
    NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug dependence and addiction: neural substrates.
    Self D
    Am J Psychiatry; 2004 Feb; 161(2):223. PubMed ID: 14754767
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacotherapy of addictive disorders.
    Ross S; Peselow E
    Clin Neuropharmacol; 2009; 32(5):277-89. PubMed ID: 19834993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid receptor antagonists in the treatment of pathological gambling.
    Coppola M; Mondola R
    J Opioid Manag; 2017; 13(4):205-206. PubMed ID: 28983886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.